Seung-Jae Song, DPM
Podiatrist · Memphis, TNNPI 1922388206
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (54.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Gentleman Orthopedic Solutions at 54.6% of the total. Reporting peaked in 2021 at $2,512 and has fallen 94.8% since, to $131 in 2025.
Across 35 payments — averaging $125.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gentleman Orthopedic Solutions$2K
- Fusion Orthopedics USA, LLC$772
- Smith+Nephew$320
- Organogenesis Inc.$290
- Nevro Corp.$212
- Amgen$103
- plus $296 from 12 others
What the payments were for
- Speaking & faculty fees$1113%
- Travel & lodging$46911%
- Food & beverage$1,41332%
- Education$2,40055%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gentleman Orthopedic Solutions | 2 | $2,400 |
| Fusion Orthopedics USA, LLC | 3 | $772 |
| Smith+Nephew | 8 | $320 |
| Organogenesis Inc. | 3 | $290 |
| Nevro Corp. | 3 | $212 |
| Amgen | 1 | $103 |
| Convatec Inc. | 2 | $51 |
| Bioventus LLC | 1 | $47 |
| Treace Medical Concepts, Inc. | 1 | $29 |
| GRT US Holding, Inc. | 2 | $27 |
| Stryker(2 entities) | 2 | $27 |
| Kerecis Limited | 1 | $25 |
| Acera Surgical, Inc. | 1 | $22 |
| KCI USA, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $13 |
| Johnson & Johnson | 1 | $13 |
| Paratek Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Apligraf$214
- REGRANEX$116
- Senza$111
- Dermagraft$111
- Puraply/Affinity/NuTech$111
- KRYSTEXXA$103
- Affinity$103
- PURAPLY WOUND MATRIX$103
- GRAFIX PL$102
- Stravix$102
How this compares
$4,393 in reported general payments places this provider in the 75th percentile of 105 podiatrist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 37 | $288 |
| Methylprednisolone | 43 | $269 |
| Diclofenac Sodium | 24 | $248 |
| Clindamycin Hcl | 27 | $179 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 32 | $173 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $111 |
| Silver Sulfadiazine | 23 | $98 |
| Ciprofloxacin Hcl | 17 | $84 |
| Tramadol Hcl | 16 | $50 |
| Amoxicillin | 11 | $18 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Memphis
- Paul HutchisonMemphis$17K
- David ShainbergMemphis$874
- Antonio KnowlesMemphis$794
- Jeffrey LovelandSparta$809K
- Michael KingNashville$190K
- Penninah KumarMt Juliet$72K
- James HarrisTrenton$49K
- Matthew NeuhausSmyrna$33K
- Sam BazrafshanChattanooga$16K
- Abshan MalikKnoxville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.